Skip to main content
Animal Welfare InitiativesAnimal Health

Durable contraception in the female domestic cat using viral-vectored delivery of a feline anti-Müllerian hormone transgene

By June 6th 2023June 20th, 2023No Comments

Document type: scientific article published in Nature Communications

Authors: Lindsey M. Vansandt, Marie-Charlotte Meinsohn, Philippe Godin, Nicholas Nagykery, Natalie Sicher, Motohiro Kano, Aki Kashiwagi, Maeva Chauvin, Hatice D. Saatcioglu, Julie L. Barnes, Amy G. Miller, Amy K. Thompson, Helen L. Bateman, Elizabeth M. Donelan, Raquel González, Jackie Newsom, Guangping Gao, Patricia K. Donahoe, Dan Wang, William F. Swanson, David Pépin


Preview: Eighty percent of the estimated 600 million domestic cats in the world are free-roaming. These cats typically experience suboptimal welfare and inflict high levels of predation on wildlife. Additionally, euthanasia of healthy animals in overpopulated shelters raises ethical considerations. While surgical sterilization is the mainstay of pet population control, there is a need for efficient, safe, and cost-effective permanent contraception alternatives. Herein, we report evidence that a single intramuscular treatment with an adeno-associated viral vector delivering an anti-Müllerian hormone transgene produces long-term contraception in the domestic cat. Treated females are followed for over two years, during which transgene expression, anti-transgene antibodies, and reproductive hormones are monitored. Mating behavior and reproductive success are measured during two mating studies. Here we show that ectopic expression of anti-Müllerian hormone does not impair sex steroids nor estrous cycling, but prevents breeding-induced ovulation, resulting in safe and durable contraception in the female domestic cat.

Publication also in Science on 6 June 2023: Hello kitty, goodbye kittens? Gene therapy spays cats without surgery

Nature Communications logo
From the Nature Communications website